Sharon Choe

Sharon Choe has a diverse and extensive work experience in the field of investor relations and business development. Sharon is currently the Head of Investor Relations at Ocugen since March 2023. Prior to that, they were the Senior Vice President & Head of Investor Outreach & Corporate Access at LaVoieHealthScience from December 2020 to July 2022. At LaVoieHealthScience, they also held the role of Senior Vice President, Business Development and Investor Relations from March 2019 to December 2020.

Before joining LaVoieHealthScience, Sharon was a Senior Vice President at The Ruth Group from November 2015 to February 2019. Sharon also worked as a Consultant at Lyfebulb, a patient empowerment platform, from July 2017 to July 2018.

In their earlier career, Sharon was a Managing Director at Life Sci Advisors from December 2011 to November 2015. Prior to that, they served as the Director, Biotech Analyst at BAM Capital LLC from February 2007 to December 2008 and at Credit Suisse Asset Management from 2003 to 2006.

Sharon started their career at UBS Asset Management as the Director, Healthcare Analyst and worked there from 1993 to 2003. Overall, Sharon Choe brings a wealth of experience in investor relations, business development, and biotech analysis to their current role at Ocugen.

Sharon Choe attended Northeastern University, but the specific dates of their enrollment, degree pursued, and field of study are not provided.